These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9479655)

  • 21. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y; Li Q; Yang T; Hussain M; Shuaib A
    J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute ischemic stroke, Part 1.
    Fullerton T
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):571-2. PubMed ID: 8908931
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M; Diener HC; Kaste M; Mau J
    Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight.
    Haley EC; Lewandowski C; Tilley BC
    Ann Emerg Med; 1997 Nov; 30(5):676-82. PubMed ID: 9360581
    [No Abstract]   [Full Text] [Related]  

  • 25. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study.
    Steiner T; Bluhmki E; Kaste M; Toni D; Trouillas P; von Kummer R; Hacke W
    Cerebrovasc Dis; 1998; 8(4):198-203. PubMed ID: 9684058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial.
    Phan TG; Demchuk A; Srikanth V; Silver B; Patel SC; Barber PA; Levine SR; Hill MD
    Cerebrovasc Dis; 2013; 35(6):560-5. PubMed ID: 23838753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability?
    Wyer PC; Osborn HH
    Ann Emerg Med; 1997 Nov; 30(5):629-38. PubMed ID: 9360575
    [No Abstract]   [Full Text] [Related]  

  • 29. Response to ethical challenges in stroke research. The NINDS rt-PA Stroke Study Group.
    Stroke; 1998 Aug; 29(8):1492-3. PubMed ID: 9707180
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
    Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
    No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.
    Kleindorfer D; Lindsell CJ; Brass L; Koroshetz W; Broderick JP
    Stroke; 2008 Mar; 39(3):924-8. PubMed ID: 18239184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanism of action of newer thrombolytic agents.
    Collen D
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):11B-15B. PubMed ID: 3117858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
    Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
    Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombolytic therapy.
    Goldhaber SZ
    Adv Intern Med; 1999; 44():311-25. PubMed ID: 9929714
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute embolic stroke treated with rt-PA during elective coronary angiography].
    Ascer E; Lessa I; Caldas JG; Frudit ME; Pereira Mde B; Baruzzi AC
    Arq Bras Cardiol; 1996 Sep; 67(3):171-3. PubMed ID: 9181710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 39. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
    Tilley BC; Lyden PD; Brott TG; Lu M; Levine SR; Welch KM
    Arch Neurol; 1997 Dec; 54(12):1466-74. PubMed ID: 9400355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
    Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.